Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Efficiency in Prior Authorization Practices
Felecia Jones, COT, BBA, Cynthia Matossian, MD, FACS, and Robert F. Melendez, MD, share how ophthalmology practices can make the PA process simpler and more efficient.
Clinical Report: Efficiency in Prior Authorization Practices
Overview
Prior authorizations (PAs) significantly impact ophthalmology practices, affecting timely treatment for conditions like retinal disease and dry eye. Strategies for improving PA efficiency include dedicated teams, ongoing training, and standardized workflows.
Background
The prior authorization process is critical in ophthalmology due to the specialty's focus on chronic disease management and procedural care. Delays in PA approvals can adversely affect patient outcomes, particularly for time-sensitive treatments. The burden of PAs also extends to clinical staff, contributing to frustration and burnout.
Data Highlights
No numerical data provided in the article.
Key Findings
PAs create significant delays in treatment for conditions such as age-related macular degeneration and diabetic macular edema.
Dedicated teams for PAs can improve efficiency and reduce staff burden.
Ongoing training on payer rules can prevent avoidable denials.
Standardized workflows and diagnosis-specific PA checklists can simplify the PA process.
Automated communication tools can reduce the time spent on repetitive patient inquiries.
Clinical Implications
Ophthalmology practices should consider establishing dedicated teams for handling PAs to streamline processes and reduce staff workload.
Conclusion
Improving the efficiency of prior authorization practices is essential for timely patient care in ophthalmology.
Neda Gioia, OD, CNS, FMCP, FOWNS, reviewed how levels of individual hormones and the balance between them help regulate tear production, inflammation, wound healing, lipid secretion, intraocular pressure (IOP), and neuroprotection, and therefore can result in a higher burden of dry eye, glaucoma, or retinal disease in women.
This article will examine the indications, clinical evidence, and practical considerations for managing severe ocular surface disease and inflammatory dry eye using scleral lenses, and offer guidance to practitioners who seek to expand their therapeutic options.
More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice
